Business · 13/03/2026Updated: 10/16/2026 · 1 min read
FDA Solicits Public Comment on Proposed Collection of Information for Investigational New Drugs
The FDA is seeking public comment on its proposed collection of information related to investigational new drugs and investigational new drug applications, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →